Alterations in secreted protein-regulated signaling pathways (e.g., leptin, adiponectin, IL-6) have been associated with increased susceptibility to obesity-associated metabolic disorders such as type 2 diabetes (T2D)2–5. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.